Immunotherapy
Publication Information
Title
Immunotherapy [English]
ISSNs
- Print: 1750-743X
- Electronic: 1750-7448
Publishers
- Future Science Group [Commercial Publisher]
- Future Medicine [Imprint]
Publisher Policy
Open Access pathways permitted by this journal's policy are listed below by article version. Click on a pathway for a more detailed view.
Published Version
[pathway a]
NoneCC BY-NC-ND
Non-Commercial Subject Repository, PMC, Institutional Website, +2
OA Fee
This pathway has an Open Access fee associated with it
OA Publishing
This pathway includes Open Access publishing
Embargo
No Embargo
Licence
CC BY-NC-ND
Location
- Author's Homepage
- Institutional Website
- Named Repository (PubMed Central)
- Non-Commercial Subject Repository
- Journal Website
Conditions
- Published source must be acknowledged with full citation
- Must link to published article
Published Version
[pathway b]
NoneCC BY
Institutional Repository, Non-Commercial Subject Repository, PMC, +2
Prerequisites
If Required by Funder
OA Fee
This pathway has an Open Access fee associated with it
OA Publishing
This pathway includes Open Access publishing
Embargo
No Embargo
Licence
- CC BY-NC
- CC BY-ND
- CC BY-NC-SA
- CC BY
- CC BY-SA
- CC BY-NC-ND
Location
- Author's Homepage
- Institutional Repository
- Named Repository (PubMed Central)
- Non-Commercial Subject Repository
- Journal Website
Conditions
- Published source must be acknowledged with full citation
- Must link to published version
Published Version
[pathway c]
NonePMC
Institutional Repository, Non-Commercial Subject Repository, PMC, +2
Prerequisite Funders
OA Publishing
This pathway includes Open Access publishing
Embargo
No Embargo
Publisher Deposit
Location
- Author's Homepage
- Institutional Repository
- Named Repository (PubMed Central)
- Non-Commercial Subject Repository
- Journal Website
Conditions
- Published source must be acknowledged with full citation
- Must link to published article
Accepted Version
[pathway a]
3m
Author's Homepage
Embargo
3 Months
Location
Author's Homepage
Conditions
Published source must be acknowledged with full citation
Accepted Version
[pathway b]
12m
Institutional Repository, Non-Commercial Subject Repository
Embargo
12 Months
Location
- Institutional Repository
- Non-Commercial Subject Repository
Conditions
Published source must be acknowledged with full citation
Accepted Version
[pathway c]
None
Any Repository
Prerequisite Funders
- Academy of Finland
- Agence Nationale de la Recherche
- Aligning Science Across Parkinson's
- Arts and Humanities Research Council
- Austrian Science Fund
- Bill & Melinda Gates Foundation
- Biotechnology and Biological Sciences Research Council
- Economic and Social Research Council
- Engineering and Physical Sciences Research Council
- FORTE
- Fonds National de la Recherche Luxembourg
- Higher Council for Science and Technology
- Howard Hughes Medical Institute
- Innovate UK
- Medical Research Council
- Narodowe Centrum Nauki
- Natural Environment Research Council
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Research Council of Norway
- Riksbankens Jubileumsfond
- Schweizerische Akademie der Geistes- und Sozialwissenschaften
- Science Foundation Ireland
- Science and Technology Facilities Council
- Slovenian Research Agency
- Templeton World Charity Foundation
- UKRI
- Vinnova
- WHO
- Wellcome Trust
Embargo
No Embargo
Location
Any Repository
Conditions
Only for cOAlition S funders
Submitted Version
None
Institutional Repository, Subject Repository, Preprint Repository, +2
Embargo
No Embargo
Location
- Author's Homepage
- Institutional Repository
- Institutional Website
- Preprint Repository
- Subject Repository
Conditions
Must be accompanied with statement that article has been submitted to journal
For more information, please see the following links:
Record Information
ID
12301
Policy IDs
420
Date Created
27 August 2010 15:57:28 UTC
Last Modified
9 March 2023 11:41:18 UTC
Sherpa Romeo information is accurate to the best of our knowledge but should not be relied upon for legal advice.